期刊
NANOMEDICINE
卷 14, 期 12, 页码 1605-1621出版社
FUTURE MEDICINE LTD
DOI: 10.2217/nnm-2018-0478
关键词
cancer metastasis; drug delivery; formulation; lymphatic; nanomedicine; PEGylation; pharmacokinetics; poly(ethylene glycol); prodrugs
资金
- NHMRC Career Development fellowship
Lymphatic metastasis plays an important role in cancer progression and prognosis. However, conventional small-molecule chemotherapy drugs inefficiently access the lymphatic system, making the effective eradication of lymphatic metastases difficult without dose-limiting toxicity. Various formulation and nanomedicine-based approaches can be used to significantly enhance the trafficking of small-molecule, peptide and protein drugs toward the lymphatic system to enhance drug exposure at sites of lymphatic cancer growth. However, a number of obstacles exist in translating improved lymphatic exposure into improved chemotherapeutic outcomes. This review highlights the opportunities and challenges inherent in employing formulation and nanomedicinal approaches to improve chemotherapeutic drug activity within the lymphatic system and, importantly, at sites of lymphatic cancer metastasis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据